1. Academic Validation
  2. Platycodin D, a novel activator of AMP-activated protein kinase, attenuates obesity in db/db mice via regulation of adipogenesis and thermogenesis

Platycodin D, a novel activator of AMP-activated protein kinase, attenuates obesity in db/db mice via regulation of adipogenesis and thermogenesis

  • Phytomedicine. 2019 Jan;52:254-263. doi: 10.1016/j.phymed.2018.09.227.
Hye-Lin Kim 1 Jinbong Park 1 Yunu Jung 1 Kwang Seok Ahn 2 Jae-Young Um 3
Affiliations

Affiliations

  • 1 Department of Pharmacology, College of Korean Medicine, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea; Basic Research Laboratory for Comorbidity Regulation, Comorbidity Research Institute, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea.
  • 2 Department of Pharmacology, College of Korean Medicine, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea.
  • 3 Department of Pharmacology, College of Korean Medicine, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea; Basic Research Laboratory for Comorbidity Regulation, Comorbidity Research Institute, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea. Electronic address: jyum@khu.ac.kr.
Abstract

Background: Platycodi Radix (root of Platycodon grandiflorum) and its active compound platycodin D (PD) has been previously shown to possess anti-obesity properties, but the underlying mechanisms remain poorly understood.

Purpose: The present study was aimed to evaluate the anti-obese effect of PD and reveal its mechanism of action.

Study design/methods: Genetically obese db/db mice were orally treated with PD for 4 weeks, and body weight gain, adipose tissue weight, serum parameters were measured. Then, assays on adipogenic factors, thermogenic factors, and AMP-activated protein kinase (AMPK) pathway were performed in PD-treated 3T3-L1 murine adipocytes, human adipose-derived mesenchymal stem cells (hAMSCs), and primary cultured brown adipocytes.

Results: PD treatment attenuated body weight gain, suppressed white adipose tissue weight and improved obesity-related serum parameters in db/db mice. Two major adipogenic factors, Peroxisome Proliferator-activated Receptor gamma (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) were decreased by PD treatment in WAT of db/db mice, 3T3-L1 adipocytes and hAMSCs. In BAT of db/db mice and primary cultured brown adipocytes, PD treatment elevated the expressions of uncoupled protein 1 (UCP1) and Peroxisome Proliferator-activated Receptor γ coactivator 1 α (PCG1α), the key regulators of BAT-associated thermogenesis. In addition, PD activated AMPKα both in vivo and in vitro. However, when AMPK was inhibited by compound C, PD treatment failed to suppress adipogenic factors and increase thermogenic factors.

Conclusions: PD improved obesity in db/db mice by AMPK-associated decrease of adipogenic markers including PPARγ and C/EBPα. PD increased thermogenic factors such as UCP1 and PGC1α in db/db mice and primary cultured brown adipocytes. AMPK inhibition nullified the effects of PD, suggesting its anti-adipogenic and thermogenic actions were dependent on AMPK pathway activation.

Keywords

AMP-activated protein kinase pathway; Adipogenesis; Obesity; Platycodin D; Thermogenesis.

Figures
Products